Therapeutic Solutions International, Inc.
TSOI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$512.27K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $512,271.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 0.24 |
| Outstanding Shares | 4,913,103,351 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.14 |
|---|---|
| PEG | -0.21 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Therapeutic Solutions International, Inc.
3 employees
CEO: Timothy George Dixon
Therapeutic Solutions International, Inc. is dedicated to modulating the immune system to address a diverse array of serious conditions. The company formulates immune-modulatory agents targeting cancers, schizophrenia, suicidal ideation,...